스타틴 시장은 2024-2029년에 30억 8,200만 달러 증가하고, 예측 기간 중 CAGR은 3.6%로 성장할 것으로 예측됩니다.
스타틴 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 고콜레스테롤혈증 유병률 증가, 심혈관 질환의 위험 요인 증가, 일반의약품(OTC)에 대한 소비자 선호도 증가에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준연도 |
2025 |
| 종료연도 |
2029 |
| 예측 기간 |
2025-2029 |
| 성장 모멘텀 |
가속 |
| 전년대비 2025년 |
3.4% |
| CAGR |
3.6% |
| 증가액 |
30억 8,200만 달러 |
본 조사는 업계의 주요 참가자로부터 인풋을 포함한 1차 정보와 2차 정보의 객관적인 조합을 사용하여 시행했습니다. 리포트에는 주요 기업의 분석과 함께 종합적 시장 규모 데이터, 지역별 분석에 의한 부문, 벤더 구도가 포함되어 있습니다. 리포트에는 과거 데이터와 예측 데이터가 있습니다.
이 보고서는 향후 수년간 스타틴 시장 성장을 주도할 주요 요인 중 하나로 높은 심혈관 질환 발병률을 꼽았습니다. 또한 소비자의 건강 지향적 성향과 선진 지역 전반의 좌식 생활 습관은 시장 수요를 크게 증가시킬 것으로 예측됩니다.
목차
제1장 개요
제2장 Technavio 분석
- 가격·수명주기·고객 구입 바스켓·채택률·구입 기준의 분석
- 인풋의 중요성과 차별화의 요인
- 혼란의 요인
- 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2024
- 시장 전망 2024-2029
제5장 시장 규모 실적
- 세계의 스타틴 시장 2019-2023
- 최종사용자 부문 분석 2019-2023
- 유형 부문 분석 2019-2023
- 약물 클래스 부문 분석 2019-2023
- 치료 영역 부문 분석 2019-2023
- 지역별 부문 분석 2019-2023
- 국가별 부문 분석 2019-2023
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제8장 시장 세분화 : 최종사용자별
- 시장 부문
- 비교 : 최종사용자별
- 병원 : 시장 규모와 예측 2024-2029
- 클리닉 : 시장 규모와 예측 2024-2029
- 기타 : 시장 규모와 예측 2024-2029
- 시장 기회 : 최종사용자별
제9장 시장 세분화 : 유형별
- 시장 부문
- 비교 : 유형별
- 합성 스타틴 : 시장 규모와 예측 2024-2029
- 천연 스타틴 : 시장 규모와 예측 2024-2029
- 시장 기회 : 유형별
제10장 시장 세분화 : 약제 클래스별
- 시장 부문
- 비교 : 약제 클래스별
- Atorvastatin : 시장 규모와 예측 2024-2029
- Simvastatin : 시장 규모와 예측 2024-2029
- Pravastatin : 시장 규모와 예측 2024-2029
- Fluvastatin : 시장 규모와 예측 2024-2029
- 기타 : 시장 규모와 예측 2024-2029
- 시장 기회 : 약제 클래스별
제11장 시장 세분화 : 치료 영역별
- 시장 부문
- 비교 : 치료 영역별
- 심혈관질환 : 시장 규모와 예측 2024-2029
- 비만 : 시장 규모와 예측 2024-2029
- 염증성 질환 : 시장 규모와 예측 2024-2029
- 기타 : 시장 규모와 예측 2024-2029
- 시장 기회 : 치료 영역별
제12장 고객 상황
제13장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2024-2029
- 아시아 : 시장 규모와 예측 2024-2029
- 유럽 : 시장 규모와 예측 2024-2029
- 세계의 기타 지역 : 시장 규모와 예측 2024-2029
- 미국 : 시장 규모와 예측 2024-2029
- 캐나다 : 시장 규모와 예측 2024-2029
- 중국 : 시장 규모와 예측 2024-2029
- 일본 : 시장 규모와 예측 2024-2029
- 독일 : 시장 규모와 예측 2024-2029
- 브라질 : 시장 규모와 예측 2024-2029
- 인도 : 시장 규모와 예측 2024-2029
- 멕시코 : 시장 규모와 예측 2024-2029
- 프랑스 : 시장 규모와 예측 2024-2029
- 영국 : 시장 규모와 예측 2024-2029
- 시장 기회 : 지역 상황별
제14장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제15장 경쟁 구도
제16장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Abbott Laboratories
- Amgen Inc.
- AstraZeneca Plc
- Aurobindo Pharma Ltd.
- Biocon Ltd.
- Concord Biotech Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Thermo Fisher Scientific Inc.
제17장 부록
KSA
The statin market is forecasted to grow by USD 3082 mn during 2024-2029, accelerating at a CAGR of 3.6% during the forecast period. The report on the statin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of hypercholesterolemia, increasing risk factors for cardiovascular diseases, and increasing consumer preference for over-the-counter (OTC) drugs.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 3.4% |
| CAGR | 3.6% |
| Incremental Value | $3082 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's statin market is segmented as below:
By End-user
By Type
- Synthetic statin
- Natural statin
By Drug Class
- Atorvastatin
- Simvastatin
- Pravastatin
- Fluvastatin
- Others
By Therapeutic Area
- Cardiovascular disorders
- Obesity
- Inflammatory disorders
- Others
By Geographical Landscape
- North America
- Asia
- Europe
- Rest of World (ROW)
This study identifies the strong incidence of chd as one of the prime reasons driving the statin market growth during the next few years. Also, growing health consciousness among consumers and sedentary lifestyle across the developed regions will lead to sizable demand in the market.
The report on the statin market covers the following areas:
- Statin Market sizing
- Statin Market forecast
- Statin Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading statin market vendors that include Abbott Laboratories, Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Biocon Ltd., Concord Biotech Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Thermo Fisher Scientific Inc.. Also, the statin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Statin Market 2019 - 2023
- Historic Market Size - Data Table on Global Statin Market 2019 - 2023 ($ million)
- 5.2 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.4 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
- 5.5 Therapeutic Area segment analysis 2019 - 2023
- Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
- 5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Statin Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by End-user
- 8.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 8.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 8.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- 8.4 Clinics - Market size and forecast 2024-2029
- Chart on Clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Clinics - Year-over-year growth 2024-2029 (%)
- 8.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 9.3 Synthetic statin - Market size and forecast 2024-2029
- Chart on Synthetic statin - Market size and forecast 2024-2029 ($ million)
- Data Table on Synthetic statin - Market size and forecast 2024-2029 ($ million)
- Chart on Synthetic statin - Year-over-year growth 2024-2029 (%)
- Data Table on Synthetic statin - Year-over-year growth 2024-2029 (%)
- 9.4 Natural statin - Market size and forecast 2024-2029
- Chart on Natural statin - Market size and forecast 2024-2029 ($ million)
- Data Table on Natural statin - Market size and forecast 2024-2029 ($ million)
- Chart on Natural statin - Year-over-year growth 2024-2029 (%)
- Data Table on Natural statin - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Drug Class
- 10.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
- 10.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 10.3 Atorvastatin - Market size and forecast 2024-2029
- Chart on Atorvastatin - Market size and forecast 2024-2029 ($ million)
- Data Table on Atorvastatin - Market size and forecast 2024-2029 ($ million)
- Chart on Atorvastatin - Year-over-year growth 2024-2029 (%)
- Data Table on Atorvastatin - Year-over-year growth 2024-2029 (%)
- 10.4 Simvastatin - Market size and forecast 2024-2029
- Chart on Simvastatin - Market size and forecast 2024-2029 ($ million)
- Data Table on Simvastatin - Market size and forecast 2024-2029 ($ million)
- Chart on Simvastatin - Year-over-year growth 2024-2029 (%)
- Data Table on Simvastatin - Year-over-year growth 2024-2029 (%)
- 10.5 Pravastatin - Market size and forecast 2024-2029
- Chart on Pravastatin - Market size and forecast 2024-2029 ($ million)
- Data Table on Pravastatin - Market size and forecast 2024-2029 ($ million)
- Chart on Pravastatin - Year-over-year growth 2024-2029 (%)
- Data Table on Pravastatin - Year-over-year growth 2024-2029 (%)
- 10.6 Fluvastatin - Market size and forecast 2024-2029
- Chart on Fluvastatin - Market size and forecast 2024-2029 ($ million)
- Data Table on Fluvastatin - Market size and forecast 2024-2029 ($ million)
- Chart on Fluvastatin - Year-over-year growth 2024-2029 (%)
- Data Table on Fluvastatin - Year-over-year growth 2024-2029 (%)
- 10.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.8 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
11 Market Segmentation by Therapeutic Area
- 11.1 Market segments
- Chart on Therapeutic Area - Market share 2024-2029 (%)
- Data Table on Therapeutic Area - Market share 2024-2029 (%)
- 11.2 Comparison by Therapeutic Area
- Chart on Comparison by Therapeutic Area
- Data Table on Comparison by Therapeutic Area
- 11.3 Cardiovascular disorders - Market size and forecast 2024-2029
- Chart on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
- 11.4 Obesity - Market size and forecast 2024-2029
- Chart on Obesity - Market size and forecast 2024-2029 ($ million)
- Data Table on Obesity - Market size and forecast 2024-2029 ($ million)
- Chart on Obesity - Year-over-year growth 2024-2029 (%)
- Data Table on Obesity - Year-over-year growth 2024-2029 (%)
- 11.5 Inflammatory disorders - Market size and forecast 2024-2029
- Chart on Inflammatory disorders - Market size and forecast 2024-2029 ($ million)
- Data Table on Inflammatory disorders - Market size and forecast 2024-2029 ($ million)
- Chart on Inflammatory disorders - Year-over-year growth 2024-2029 (%)
- Data Table on Inflammatory disorders - Year-over-year growth 2024-2029 (%)
- 11.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 11.7 Market opportunity by Therapeutic Area
- Market opportunity by Therapeutic Area ($ million)
- Data Table on Market opportunity by Therapeutic Area ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.5 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.10 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 13.11 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.12 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 13.13 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 13.14 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 13.15 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 13.16 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.1 Market drivers
- 14.2 Market challenges
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- 16.2 Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 16.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- 16.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 16.7 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
- 16.8 Biocon Ltd.
- Biocon Ltd. - Overview
- Biocon Ltd. - Business segments
- Biocon Ltd. - Key offerings
- Biocon Ltd. - Segment focus
- SWOT
- 16.9 Concord Biotech Ltd.
- Concord Biotech Ltd. - Overview
- Concord Biotech Ltd. - Product / Service
- Concord Biotech Ltd. - Key offerings
- SWOT
- 16.10 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- 16.11 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 16.12 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 16.13 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.5 Data procurement
- 17.6 Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
